As of July 2026, dental practice mergers and acquisitions are accelerating after a relatively subdued 2024–2025 period. The TUSK Practice Sales Q3 2026 report — one of the most closely watched barometers of dental M&A activity — reveals that deal volume is climbing, valuations are evolving, and the competitive dynamics between dental service organizations (DSOs), private equity groups, and independent buyers are shifting in ways that directly affect Canadian practice owners considering a transition.
What the Numbers Show: 175 Reported Transactions in Six Months
According to TUSK Practice Sales, at least 175 dental practice locations were sold to DSOs, private equity groups, and other acquirers in the first half of 2026. While this represents a meaningful recovery from the deal slowdown of 2024, it remains below the peak volumes seen during the 2021–2022 consolidation frenzy.
The American Dental Association places the overall dental industry at roughly 35% consolidated — meaning approximately one in three dental practice locations now operates under some form of group or corporate ownership. In Canada, the consolidation rate is tracking slightly behind the U.S., but major players like dentalcorp (which completed a $2.2 billion take-private in 2025) continue to acquire aggressively across Ontario and nationally.
Why the Rebound: Debt Restructuring Cleared the Path
The 2024–2025 slowdown was largely driven by financial pressure on overleveraged DSOs. Dental Care Alliance, one of the largest U.S. dental groups, completed a debt restructuring in early 2026 that eliminated more than $1.1 billion in obligations and secured $95 million in fresh capital. This pattern — distressed groups recapitalizing, then resuming acquisitions — is now playing out across multiple platforms.
For Canadian dentists, the implication is straightforward: buyer appetite is increasing, and groups that were sidelined by debt problems in 2024 are returning to the market with fresh capital and new mandates to grow.
Valuation Compression: What TUSK Is Signalling
TUSK's report notes that dental practice valuations are "poised to compress" as the industry hits a mid-cycle correction. What does this mean practically?
- Peak multiples are behind us. The 8–12x EBITDA multiples that characterized the 2021 buying frenzy have softened. Buyers are more disciplined, and debt costs remain elevated relative to the near-zero rates of 2020–2021.
- Quality still commands premium. Practices with strong hygiene recall rates, diversified payer mixes, and modern digital workflows continue to attract competitive offers. The compression is concentrated in practices with declining patient bases or heavy dependence on a single provider.
- Canadian vs. U.S. dynamics differ. While U.S. DSO valuations are compressing, Canadian dental groups face a more fragmented competitive landscape with fewer publicly traded entities following dentalcorp's take-private transaction.
The Canadian Landscape: What Ontario Practice Owners Should Watch
Several factors make the Canadian dental M&A market distinct from its U.S. counterpart in July 2026:
CDCP impact on valuations. The Canadian Dental Care Plan, now serving over 3.4 million enrolled Canadians, is reshaping practice revenue mixes. Practices with high CDCP patient volumes may face valuation questions from buyers concerned about government reimbursement sustainability — much as U.S. practices with heavy Medicaid exposure face scrutiny.
Ontario workforce constraints. The Royal College of Dental Surgeons of Ontario (RCDSO) continues to process record numbers of new registrations, but hygienist shortages persist in suburban markets. Buyers are increasingly factoring staffing stability into their valuation models.
Interest rate trajectory. The Bank of Canada's rate decisions through 2026 directly affect acquisition financing. Each 25-basis-point cut improves buyer capacity and can reaccelerate deal flow.
What This Means for Practice Owners Not Yet Selling
Even if a sale is five or ten years away, the current M&A environment contains actionable intelligence for every Canadian practice owner:
Pro Tip: Start tracking your practice's trailing-twelve-month EBITDA now, even if a sale is years away. Buyers evaluate trends, not snapshots — three years of documented financial improvement can add 1–2x to your eventual multiple.
Build transferable systems. The single largest valuation discount is "key-person risk" — practices where revenue is inseparable from one provider. Delegating hygiene production, building associate relationships, and systematizing patient recall all reduce this risk.
Digital infrastructure matters. Practices with integrated digital workflows (intraoral scanners, digital treatment planning, cloud-based practice management) consistently attract higher offers than those requiring post-acquisition technology investment.
The DSO Debt Lesson
The Dental Care Alliance debt restructuring — $1.1 billion eliminated — is not an isolated event. Multiple U.S. dental groups have quietly restructured or sold assets in 2025–2026. The lesson for independent practitioners: the "DSO premium" is not guaranteed to rise indefinitely. Groups that overpaid in 2021 are now rationalizing their portfolios, and some are divesting locations that don't meet performance benchmarks.
This creates opportunity for well-capitalized Canadian buyers — including partnerships between independent dentists — to acquire locations at more reasonable valuations than were available during the peak.
Looking Ahead: H2 2026 Predictions
Based on the TUSK report and broader market signals, the second half of 2026 is likely to bring:
- Continued deal volume growth, with Q3 and Q4 expected to exceed H1 totals
- More cross-border activity, with U.S.-based groups expanding into Canadian markets where valuations remain comparatively attractive
- Increased scrutiny on revenue quality, with buyers differentiating between practices with strong organic growth versus those propped up by temporary demand surges
- Greater importance of IPAC compliance and operational documentation as due diligence standards tighten
Pro Tip: If you're considering a practice transition within the next 3–5 years, get a formal valuation assessment now — not to sell immediately, but to identify the specific metrics and improvements that would maximize your eventual transaction value.
Frequently Asked Questions
Q: How does dental industry consolidation affect independent practices in Ontario?
Consolidation creates both competitive pressure and opportunity for independent Ontario dental practices. DSOs and corporate groups can leverage purchasing power and marketing budgets, but independent practices that differentiate through patient relationships, specialized services, and community presence continue to thrive. The 35% consolidation rate means roughly two-thirds of practices remain independent.
Q: What EBITDA multiple can a Canadian dental practice expect in 2026?
Multiples vary significantly based on practice size, location, and quality. General practices in urban Ontario markets currently see offers in the 4–7x EBITDA range for standard transactions, with premium multiples reserved for large, multi-provider practices with strong growth trajectories. Specialty practices may command higher multiples. Consult a dental practice broker familiar with the Canadian market for current benchmarks.
Q: Should I sell my dental practice now or wait for better valuations?
The TUSK Q3 2026 report suggests valuations are compressing, not expanding. However, timing a sale to the market is less important than timing it to your practice's performance trajectory. A practice showing two years of revenue growth will command a better multiple than one with declining production, regardless of market conditions. Focus on building value now; market timing is secondary.
EBIKO Dental will continue monitoring dental industry M&A developments and their implications for Canadian practice owners. For the latest dental industry analysis and clinical supply insights, visit ebiko.ca.